Documente Academic
Documente Profesional
Documente Cultură
REFERENCIAS BIBLIOGRÁFICAS
[1] Juan Jaramillo Antiñón (1991) El cáncer. Fundamentos de oncología, página 89.
Editorial de la Universidad de Costa Rica.
[2] Muñoz, A. (2004). Cáncer: genes y nuevas terapias. España: Hélice.
[3] Gazdar A, Franklin WA, Brambilla E, Hainaut P, Yakota J, Harris CC. (2004)
Genetic and molecular alterations. In: Pathology and genetics, tumours of the lung,
pleura, thymus and heart, Travis WD, Brambilla E, Müller-Hermelink K, Harris CC,
eds. IARC Press, publisher.
[4] Breitbart M, Rohwer F (2005). Here a virus, there a virus, everywhere the same
virus. Trends Microbiol 13 (6): 278–84.
[5] Lawrence CM, Menon S, Eilers BJ, et al. (2009). Structural and functional studies
of archaeal viruses. J. Biol. Chem. 284 (19): 12599-603.
[6] Microbiologybook.org. (2018). Virus oncogenicos. [online] Available at:
http://www.microbiologybook.org/Spanish-Virology/spanish-chapter6.htm
[Accessed 8 Apr. 2018].
[7] Robert Belshaw; Pereira V; Katzourakis A; Talbot G; Paces J; Burt A; Tristem M.
(2004). Long-term reinfection of the human genome by endogenous retroviruses.
Proc Natl Acad Sci USA 101 (14): 4894-99
[8] Murphy FA, Gibbs EPJ, Horzinek MC, Studdert MJ. (1999). Veterinary Virology.
3rd Ed. Academic Press,
[9] Carrasco, L., Almendral del Rio, J.M. (2006). Virus patógenos. Hélice.
[10] Noticias y Artículos de Salud, Medicina, Hábitos de Vida y Enfermedades.
(2018). La relación virus – cáncer. [online] Available at:
http://esferasalud.com/enfermedades/cancer-2/relacion-virus-cancer [Accessed 8
Apr. 2018].
[11] José Moreno Nogueira (2015). El largo camino de la historia del cáncer.
Asociación para el Progreso de la Oncología (APO). Sevilla.
[12] Pagano, JS; Blaser, M; Buendia, MA; Damania, B; Khalili, K; Raab-Traub, N;
Roizman, B (2004). «Infectious agents and cancer: criteria for a causal relation».
Semin Cancer Biol 14 (6): 453–71.
[13] D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH,
Gillison ML. (2007). Case-control study of human papillomavirus and oropharyngeal
cancer. New England Journal of Medicine.
[14] Iannacone MR, Gheit T, Waterboer T, Giuliano AR, Messina JL, Fenske NA,
Cherpelis BS, Sondak VK, Roetzheim RG, Michael KM, Tommasino M, Pawlita M,
Rollison DE. (2012) Case-control study of cutaneous human papillomaviruses in
squamous cell carcinomas of the skin. Cancer Epidemiol Biomarkers Prev.
[15] Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J. (2000).
Sexual behaviour and smoking as determinants of cervical HPV infection and of
CIN3 among those infected: a case-control study nested within the Manchester
cohort. British Journal of Cancer.
[16] Giuliano AR, Sedjo RL, Roe DJ, Harri R, Baldwi S, Papenfuss MR, Abrahamsen
M, Inserra P. (2002). Clearance of oncogenic human papillomavirus (HPV) infection:
effect of smoking (United States). Cancer Causes Control.
[17] McCann MF, Irwin DE, Walton LA, Hulka BS, Morton JL, Axelrad CM. (1992).
Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and
nonsmokers. Cancer epidemiology, biomarkers & prevention.
[18] Schiffman M, Castle PE. (2003). Human papillomavirus: epidemiology and
public health. Archives of Pathology and Laboratory Medicine.127(8):930-4.
[19] Zur Hausen H. (2002). Papillomaviruses and cancer: from basic studies to
clinical application. Nature Reviews. Cancer.
[20] Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS,
Markowitz LE. (2007). Prevalence of HPV infection among females in the United
States. JAMA.
[21] Burchell AN, Winer RL, de Sanjosé S, Franco EL. (2006). Chapter 6:
Epidemiology and transmission dynamics of genital HPV infection. Vaccine.
[22] Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. (2007).
"Human papillomavirus and cervical cancer." Lancet.
[23] Chaturvedi AK. (2010). Beyond cervical cancer: burden of other HPV-related
cancers among men and women. J Adolesc Health.